Baiair Medicine Invests Additional RMB 43 Million in SicaGene, Stake Rises to 19.77%

China Interview Network Data  Baheal Medical(301015) Announcement: The company has made an additional investment of 43 million yuan in cash to SicaGene (Beijing) Biotechnology Co., Ltd. After this additional investment, the company holds 19.7698% of SicaGene's equity. As of the date of the announcement, the company has signed the "Additional Investment Agreement" with all parties involved and has fully paid the investment amount to SicaGene. The transaction has been completed.